Market Insights report
The Oncology Drugs market covers drugs to treat cancer, including chemotherapy and immunotherapy as well as oncology orphan drugs. These therapies are used for solid tumors and hematologic cancer. The medications in this market are mainly physician-administered drugs. Excluded are radiation therapy and medical devices.
What's included?
Oncology Drugs is the largest market of the Pharmaceuticals market. Its growth rate is expected to remain very high. This growth is mainly driven by immuno-oncology. The market is dominated by a comparatively small number of high-priced drugs, which makes individual therapies typically very expensive. Most of the revenue is generated in wealthier countries. For several leading pharmaceutical companies, oncology is their largest market. The pharmaceutical industry is characterized by disruptions due to innovative drugs and expiring patents. Research and development, which involves large costs as well as high risks and considerable uncertainties, is the main market driver.
Overview
Market numbers
We provide information on industries, companies, consumers, trends, countries, and politics, covering the latest and most important issues in a condensed format.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)